VO2MAX & RMR: Grow Your Business With Breath Analysis
George Kouyoufas — Strategic Partnership Executive @Pnoē
George Kouyoufas is the Strategic Partnership Executive at PNOĒ, a health technology company focused on metabolic analysis. He specializes in VO₂max and resting metabolic rate testing, helping health, fitness, and wellness professionals use breath analysis to improve client outcomes and grow their businesses.
This talk explores how VO₂max and RMR—two of the most powerful biomarkers in longevity and performance—can transform both client outcomes and business growth. We will dive into the scientific foundations of cardiometabolic breath analysis, examine real-world implementation strategies, and demonstrate how objective diagnostics elevate programming across GLP-1 protocols, peptide therapies, hormone optimization, fitness, and recovery services. Attendees will gain actionable insights on integrating metabolic screening into their ecosystem to drive personalization, validate auxiliary services, and create measurable, scalable revenue growth.
VO2 max is the number one most important longevity predictor and the most important component in decreasing all-cause mortality. Using this data as a compass is a great way to convey to clients exactly what they need to do for their health.
Summary
- VO2 Max is a primary predictor of longevity and all-cause mortality, while Resting Metabolic Rate measured through breath analysis provides the most accurate assessment of caloric needs.
- Portable breath analysis technology offers clinical-grade accuracy once restricted to labs, allowing wellness providers to conduct metabolic testing in any environment with minimal overhead.
- Outsourcing data interpretation and programming to cloud-based experts eliminates the need for full-time specialists like dietitians, making high-end metabolic services more accessible and scalable.
- Metabolic reports serve as a roadmap for personalized nutrition and exercise, helping businesses improve client retention by pivoting from reactive treatments to proactive, data-driven health plans.
- An integrated digital ecosystem centralizes data from wearables and hundreds of biomarkers, using automated logic to recommend specific bio-optimization services based on physiological needs.
Article
Breath, Data, And The New Business Of Longevity
George Kouyoufas At Hololife Longevity Cote D'Azur Made The Case For Turning Metabolic Testing Into A Scalable Wellness Model
On 12 March 2026 in Nice, France, at Hololife Longevity Cote d'Azur, George Kouyoufas delivered a presentation with a title that sounded as commercial as it did clinical: *VO2MAX & RMR: Grow Your Business With Breath Analysis*. Yet beneath the language of growth and scalability lay a sharper proposition, one that cut to the heart of modern longevity culture: if health is increasingly measured, personalised and sold through data, then breath may become one of its most powerful currencies.
Kouyoufas, Strategic Partnership Executive at PNOĒ, stood before an audience of wellness and longevity professionals and argued that two markers, VO2 max and resting metabolic rate, offered more than physiological insight. They offered a blueprint for a new kind of business, one built not on episodic treatments and passing enthusiasm, but on continuous assessment, repeat engagement and data-backed intervention.
Why Oxygen Became The Story
Kouyoufas framed his talk around a simple but resonant truth. “We are very dependent on oxygen, and the way we utilize it is of the utmost importance,” he said, reminding the room that respiration, circulation and metabolism are not separate systems but intimately linked expressions of how the body survives, adapts and ages.
VO2 max, long familiar in elite sport and clinical exercise physiology, was presented as more than a fitness metric. Kouyoufas described it as a leading predictor of longevity and all-cause mortality, echoing the growing body of evidence that has elevated cardiovascular efficiency from athletic concern to mainstream health imperative. The test itself remains demanding: a subject reaches peak exertion on a treadmill, bike or rower while breath and recovery are measured in real time. But in Kouyoufas’s telling, the hardship of the test was precisely what made it so revealing.
Resting metabolic rate, or RMR, carried a different kind of authority. If VO2 max showed how the body performed under strain, RMR revealed what it consumed in stillness. Kouyoufas was careful to distinguish it from the rough estimates generated by body composition machines and standard formulae. Basal metabolic calculations, he said, often reduced human physiology to age, height, weight and sex, flattening muscular bodies into misleading categories and ignoring the deeper variation of real metabolism. Clinical-grade indirect calorimetry, by contrast, offered what he described as the most accurate way to understand caloric need.
From Lab Equipment To Portable Promise
For decades, this kind of testing belonged to laboratories, universities and specialist hospital departments. Kouyoufas recalled that traditional metabolic analysers were cumbersome, expensive and fixed in place, often requiring dedicated staff and significant infrastructure. In that model, breath analysis remained powerful but inaccessible.
The promise of PNOĒ, as he described it, was to shrink that world into something portable, cloud-based and commercially viable. The company’s device, he said, delivered clinical-grade indirect calorimetry in a compact format that could be carried to a client’s home, a clinic, or even a yacht. The image was not accidental. In the luxury wellness economy that stretches from Monaco to the Côte d’Azur, convenience is not a detail. It is part of the product.
Kouyoufas stressed that portability did not mean compromise. He pointed to validation work conducted with US institutions including the Veterans Affairs Department, Georgetown and Rutgers, and to PNOĒ’s wider use across a broad spectrum of partners, from Mount Sinai’s cardiology department to Equinox and Red Bull Racing. The message was clear: this was not wellness theatre dressed in scientific language, but a technological ecosystem seeking legitimacy in both research and commerce.
Twenty-Three Biomarkers And A Single Narrative
What made the pitch more ambitious was that the device was not sold as a simple test. Kouyoufas described a platform that automated the interpretation of twenty-three biomarkers, among them fat-burning efficiency, respiratory coordination and indicators linked to mitochondrial function. He argued that these metrics allowed providers to detect more than poor fitness. They could reveal patterns of hyperventilation, inefficient recovery, low metabolic output and deeper physiological strain.
“Our respiratory, cardiovascular, and metabolic systems are very much interconnected,” he said.
This was perhaps the most compelling theme of the session: the insistence that modern health professionals should stop treating the body as a collection of isolated complaints. Breath, in Kouyoufas’s presentation, became an organising principle, a way to translate complexity into an actionable hierarchy. “Accessing this physiological information gives you a clear sense of priority on what you need to do and how you can go about doing it,” he said.
That priority mattered not only for individual clients but for businesses trying to retain them.
The Retention Problem In Wellness
There was a quietly devastating observation buried in the talk. Many wellness centres, Kouyoufas suggested, were trapped in a reactive economy. A client tried cryotherapy, red light therapy, IV drips or compression boots, felt better for a moment, then saw little reason to return. Relief, while powerful, was fleeting. Without a measurable plan, it failed to become habit.
This was where metabolic testing entered not as diagnosis alone but as commercial architecture. Kouyoufas argued that breath analysis could become the anchor service through which all other offerings were organised. A client no longer came in simply to feel better. They came in with a map of deficiencies, targets and progress markers. The report became a compass. Services such as red light, cryotherapy or recovery therapy could then be recommended against identifiable physiological needs rather than marketed as generic enhancements.
In that shift from reactive to proactive, wellness centres gained something more durable than a treatment sale. They gained a reason for clients to come back.
Outsourcing Expertise In The Age Of Automated Interpretation
One of the more revealing aspects of the presentation was how openly it addressed labour. The old model of advanced testing required exercise physiologists, sports scientists, dietitians and significant interpretation time. Kouyoufas offered a different proposition: let the machine collect the data, let the cloud process it, and let external analysts turn it into reports, consultations and recommendations.
For providers, this was presented as liberation. Clinics could offer high-end metabolic testing without employing a full-time specialist. Reports could be generated centrally. Virtual consultations could explain the findings. Nutrition and exercise plans could be delivered through an app. The system, in other words, converted specialist knowledge into scalable service.
It also reflected a wider shift in health technology, where the value increasingly lies not just in measurement but in packaging interpretation for rapid use. PNOĒ’s ecosystem, as Kouyoufas described it, integrated wearable data from devices such as Apple Watch, Garmin, Fitbit, Oura and Whoop, while also allowing providers to upload and visualise more than 225 laboratory biomarkers. The result was a dashboard that promised total synthesis, one interface for bloods, wearables, metabolism and personalised programming.
Personalisation As Product
In longevity culture, personalisation has become a near-sacred word, often overused and underdefined. Kouyoufas tried to give it substance. The system’s recommendations, he said, could extend from training zones and recovery work to nutrition plans shaped by culture, preference and restriction. He offered an example of a pescatarian client who preferred Indian cuisine and wanted to build muscle, a scenario used to demonstrate the platform’s ability to move beyond bland meal-plan templates and into genuinely tailored dietary design.
He also highlighted the role of RMR in managing medically assisted weight loss, particularly GLP-1 programmes. If appetite suppression changed how clients ate, then accurate metabolic data, he argued, became critical in ensuring proper caloric and micronutrient intake. Retesting every two to three months would allow practitioners to revise recommendations in line with changing physiology.
“It is not only about increasing our VO2 max and metabolic rate; it is also vital that as we age, we preserve our biomarkers,” he said.
That line landed because it captured something larger than the device itself. The aspiration of longevity is not simply improvement. It is preservation against decline, a holding action against time.
A Wellness Industry Learning To Speak In Evidence
Kouyoufas’s presentation worked because it understood the anxieties of its audience. Wellness providers today face a market that demands scientific credibility, measurable outcomes and premium service, all while resisting bloated staffing models and inconsistent retention. Breath analysis, in this context, was presented as an elegant answer: clinically grounded, visually intelligible, operationally light and commercially expandable.
Yet what lingered was not only the business logic. It was the cultural shift beneath it. The body that once visited a spa for relaxation now arrives with wearable data, bloodwork, optimisation goals and a hunger for explanation. The provider who once offered treatment now must offer interpretation, continuity and proof. In that changing landscape, technologies like PNOĒ are not merely tools. They are attempts to redefine what a wellness business is for.
Kouyoufas closed on a note of community rather than commerce. “We are all looking to optimize our health and wellness journeys and spread that knowledge to our clients, our colleagues, and our friends,” he said.
It was an appealing sentiment, even generous. But at Hololife Longevity Cote d'Azur in Nice, the deeper message was harder edged and unmistakable. The future of wellness may belong to those who can turn invisible physiology into visible strategy, and then sell that strategy back to us as the path to a longer life.
Part of Hololife Longevity Cote d'Azur